Ivan Worthington

Ivan Worthington serves as a key procurement lead within the Defense Health Agency, overseeing the acquisition of advanced analytical laboratory instrumentation and associated diagnostic technologies critical to military medical readiness. He manages complex contract actions aligned with the agency’s mission to modernize clinical workflows and ensure the integrity of global health data infrastructure. His portfolio primarily focuses on high-precision equipment used in battlefield diagnostics, pharmaceutical quality control, and laboratory automation, ensuring compliance with DoD standards for reliability and cybersecurity. Worthington’s acquisitions directly support operational medicine, clinical research, and force health protection across deployed and garrisoned medical facilities. He maintains consistent partnerships with specialized technology providers including Dependable On-Site Scan & Shred, Inc., Hanith Bioscience, LLC, Livion Technology, LLC, I-2-I Solutions, Inc., and Draeger, Inc. These vendors supply integrated lab systems, biosafety instrumentation, diagnostic software, and medical-grade analytics platforms. His contracting approach emphasizes technical interoperability, validation of FDA-cleared or CE-marked devices, and adherence to MIL-STD specifications for ruggedized deployment. Relationships are characterized by long-term performance-based contracting, with an emphasis on vendor responsiveness, service-level agreements, and post-deployment technical support. Worthington’s procurement strategy reflects a singular focus on open competition, with 100% of awards issued under no set-aside classifications. He does not prioritize 8(a), HUBZone, or SDVOSB programs, instead prioritizing technical capability and mission-critical performance over socioeconomic preferences. This approach ensures access to the most advanced, validated solutions required for high-acuity military healthcare environments. His primary NAICS focus is 334516—Analytical Laboratory Instrument Manufacturing—reflecting deep expertise in procuring mass spectrometers, PCR analyzers, hematology systems, and automated clinical chemistry platforms. He specializes in acquisitions requiring stringent calibration, traceability, and integration with DoD health information systems, demonstrating a technical command over laboratory automation, point-of-care diagnostics, and bioanalytical instrumentation essential to force health sustainment.